Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	1.26B -27.5%
Revenue (ttm)	700.07M +0.7%
Net Income	117.29M -10.9%
EPS	6.35 -10.8%
Shares Out	18.42M
PE Ratio	10.76
Forward PE	n/a
Dividend	5.00 (7.32%)
Ex-Dividend Date	Jun 13, 2025

Volume	8,163
Average Volume	36,413
Open	67.50
Previous Close	67.40
Day's Range	66.70 - 68.30
52-Week Range	64.60 - 117.50
Beta	0.19
RSI	41.74
Earnings Date	Aug 7, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2025, Winston Medical Supply's revenue was 700.07 million, an increase of 0.72% compared to the previous year's 695.08 million. Earnings were 117.29 million, a decrease of -10.87%.